Product Research and Development

Product Research and Development

Pipeline


Field Product Target IP Indications Preclinical IND Phase 1 Phase 2 Phase 3 NDA Going public
Chronic diseases CGT-8012DPP4 Global Diabetes
 
Cancer-fighting CGT-6321FGFR/VEGFR Global Solid tumor
 
Cancer-fighting CGT-9475 ALK Global Non-small cell lung cancer
 
Cancer-fighting CGT-1881CXCR4 Global Blood cancer
 
Cancer-fighting CGT-1967 CDK Global Blood cancer
 
Chronic diseases CGT-2201DPP4/SGLT2 Global Diabetes
 
Rare disease Teriflunomide DHODH Mainland China Relapsing-remitting multiple sclerosis